Sex, intimacy and Parkinson’s disease: an expert guide
Health & Fitness
Author: Sophie BatesPublished: 19 May 2022
Prep: Cook: Serves:
We round up our four-part series on sex, intimacy and Parkinson’s, in which sex therapist, Gila Bronner, and nurse consultant, Orna Moore, share their expert advice – from practical tips on how to encourage intimacy in a relationship post-diagnosis to the importance of seeking professional help
1. Intimacy, sexuality and Parkinson’s
In the first part of the series, Gila and Orna discuss the importance of intimacy, and give a four-step, practical guide on ways to improve closeness in a relationship.
Intimacy, they explain, is an area that “frequently goes unnoticed and un-discussed”. The two experts recommend spending quality time with your partner, ensuring you both have moments alone to relax, committing to intimate time without the pressure to move on to sex, and sexual time.
“Couples need these four elements, even if some time passes without realising all four of them. It is important to invest in intimacy in a relationship.”
Gila and Orna emphasise that people with Parkinson’s may not realise that their condition is the cause of their sexual dysfunction, which is why it is important to talk about any issues with medical professionals – and for healthcare professionals to encourage this discussion.
“A loving relationship includes encouragement of intimacy, sensuality, companionship, and friendship, as well as continued knowledge and understanding about the effects that one’s health conditions, medications, and treatment have on sexuality and functioning.”
Gila and Orna share ways to ensure the wellbeing of both partners, such as respecting each other’s needs, having personal time away from one another, sleeping in separate beds if sleep is being disrupted, maintaining intimacy even if it’s not sexual, having strong communication and making small, thoughtful gestures that the other will appreciate.
“Spouses and care-partners frequently face contradictory roles,” they explain. “On one hand, as intimate partners, they may have their own needs for intimacy and sexual activity. On the other hand, they are required to function as caregivers who cope with the implications of a chronic progressive illness.”
In the final part of the series, Gila and Orna discuss coping with disturbed sexual function – one of the most common non-motor symptoms in people with young onset Parkinson’s – and share the difficulties many face of sustaining a sex life due to lack of time and other priorities.
“Young people with Parkinson’s experience the disease differently. They are coping with its various symptoms while also being in the middle of life challenges.”
They say openness is crucial to sustaining a healthy sexual relationship. To tackle any issues, they advise seeking professional help when necessary, being honest with one another, and being open with children about the effects of Parkinson’s.
Orna Moore is a nurse consultant, working with families with neurodegenerative diseases. She works at the Department of Neurology, Tel Aviv Medical Center, Israel.
Gila Bronner is a sex therapist specialising in sexual rehabilitation. She is director of the Sex Therapy Service at the Sexual Medicine Center, Tel Aviv, and a sex therapist at the Institute of Movement Disorders, Sheba Medical Center, Israel.
Tune into our love-themed podcast this Valentine’s Day
Two guests on dating, relationships, sex and Parkinson’s disease
5 hours ago
Could a sea sponge support the search for Parkinson’s disease treatments?
How could a molecule in a sea sponge help treat Parkinson’s and similar conditions? Researchers at the University of California, Los Angeles (UCLA), in the US, recently explored this question. Their findings were published in the journal ‘Science’. The team examined a molecule known as lissodendoric acid A, which appears to counteract other molecules that damage DNA, proteins and whole cells – and was recently discovered in a sea sponge. The research team used an oft-neglected compound called a cyclic allene to control a step in the chain of chemical reactions, which enabled them to create a version of the molecule in a lab. Scientists believe that the ability to synthetically produce lissodendoric acid A will help them assess whether it can inform future therapies for conditions like Parkinson’s. UCLA’s Professor Neil Garg, the corresponding author of the study, said: “We hope others will also be able to use cyclic…
Study finds just six minutes of daily exercise might delay onset of Parkinson’s disease
Regular exercise is a common therapeutic strategy for people with Parkinson’s. Now, a study from New Zealand has suggested that daily physical activity might even delay the onset of this condition. Published in ‘The Physiological Society’, the study focused on a protein called brain-derived neurotrophic factor (BDNF) – which has previously been shown to boost cognitive performance. The researchers assessed the impact of fasting and physical activity on BDNF production in 12 people aged 18 to 56. The tests involved fasting and completing exercises of varying intensity, such as cycling for six minutes, as well as combinations of both fasting and physical activity. The results showed that brief, intense exercise was the best option for increasing the production of BDNF – with the protein increasing by a factor of four to five times compared to light exercise or fasting. Because BDNF can protect the brain from cognitive decline, the findings could…
Machine learning may help predict risk of freezing of gait in Parkinson’s disease
Difficulty taking steps forward, often referred to as the freezing of gait (FOG), is a common symptom experienced by people with Parkinson’s and one that can be difficult to predict. China-based researchers suggest that machine learning – artificial intelligence (AI) that uses algorithms to analyse data – could help predict the risk of freezing of gait developing in the early stages of the condition. Their study, published in ‘npj Parkinson’s Disease’, gave laboratory and clinical data to a machine learning model brain. This information was collected from 158 adults with untreated early-stage Parkinson’s and 73 healthy adults over a five-year period. They found that the risk of FOG could be predicted with an accuracy rate of up to 78%. The study authors suggested that machine learning methods “have the potential to help predict future FOG in patients with early Parkinson’s at an individual level”.